Cargando…
Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries
BACKGROUND: Strokes cause an estimated annual health care burden of 170 billion euros across Europe. Atrial fibrillation is one of the major risk factors for stroke and increases the individual risk 4.2-fold. But prevention with anticoagulants may reduce this risk by 70%. Screening methods are emplo...
Autores principales: | Wahler, Steffen, Birkemeyer, Ralf, Alexopoulos, Dimitrios, Siudak, Zbigniew, Müller, Alfred, von der Schulenburg, Johann-Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882287/ https://www.ncbi.nlm.nih.gov/pubmed/35218421 http://dx.doi.org/10.1186/s13561-022-00362-2 |
Ejemplares similares
-
A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany
por: Birkemeyer, Ralf, et al.
Publicado: (2020) -
Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors
por: Wahler, Steffen, et al.
Publicado: (2022) -
Short term cost effectiveness of a regional myocardial infarction network
por: Birkemeyer, Ralf, et al.
Publicado: (2013) -
Patient perspective on the management of atrial fibrillation in five European countries
por: Bakhai, Ameet, et al.
Publicado: (2013) -
Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany
por: Wahler, S, et al.
Publicado: (2020)